Webcast Series:
Diabetes and the Heart
This webcast is part of the inaugural effort of the Joslin Diabetes Center and Cleveland Clinic partnership. These two institutions, which are among the largest and most respected academic providers of CME, believe that the most reach and impact can be achieved in continuing medical education through innovative collaboration. By combining the institutions’ world-class clinical care protocols and cutting-edge knowledge in both diabetes and cardiac care, this partnership is able to engender the largest reach more efficiently and effectively.
It is well known that patients with diabetes and the cardiometabolic syndrome are at increased risk for developing cardiovascular disease. With the increased prevalence of the cardiometabolic syndrome and its comorbidities, the need to optimize preventive and therapeutic interventions is a major focus of most clinicians in primary care. Clinicians need to recognize the signs and symptoms of the cardiometabolic syndrome and initiate early and effective preventive interventions. However, timely diagnosis and appropriate treatment are equally as important to reduce eventual morbidity and mortality.
| Diabetes and Glycemic Control - Endocrine | |
| Estimated Time: 1 hour, 30 minutes Release Date: November 4, 2009 Type: Online Webcast |
Technical Requirements: None Expiration Date: November 14, 2012 Specialties: Endocrinologist, Cardiologist, Internal Medicine, Family Practice & Subspecialists |
| Cardiometabolic Screening and Hospital Care | |
| Estimated Time: 2 hours, 45 minutes Release Date: November 12, 2009 Type: Online Webcast |
Technical Requirements: None Expiration Date: November 12, 2012 Specialties: Endocrinologist, Cardiologist, Internal Medicine, Family Practice & Subspecialists |
Series Objectives
- Describe the physiologic and clinical interrelationships between diabetes and other components of the cardiometabolic syndrome, and summarize their effect on increased cardiovascular risk.
- Identify the components of the cardiometabolic syndrome, their clinical definitions, and their targeted treatment goals.
- Evaluate the cardiometabolic risk status of at-risk individuals in the outpatient and hospital settings.
- Describe protocols for cardiovascular evaluation and diagnosis in the patient with components of the cardiometabolic syndrome.
- Describe unique clinical characteristics and treatment concerns of coronary artery disease and congestive heart failure in patients with diabetes.
Activity Directors
Richard S. Beaser, MD
Medical Executive Director of Professional Education
Joslin Diabetes Center
Boston, MA
James B. Young, MD
Institute Chairman
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, OH
Robert S. Zimmerman, MD
Director, Fellowship Program
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, OH
This CME activity was produced by
the Cleveland Clinic Endocrinology and Metabolism Institute,
the Center for Continuing Education, and the Joslin Diabetes Center.
